Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer-Reference-Cited by-同舟云学术

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

Published:2015-08-27 Issue:2 Volume:5 Page:e1078057
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Bramante Simona,Koski Anniina,Liikanen Ilkka,Vassilev Lotta,Oksanen Minna,Siurala Mikko,Heiskanen Raita,Hakonen Tiina,Joensuu Timo,Kanerva Anna,Pesonen Sari,Hemminki Akseli

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1078057

Reference49 articles.

1. Microarray-Based Gene Expression Profiling for Molecular Classification of Breast Cancer and Identification of New Targets for Therapy

2. Neoadjuvant, Anthracycline-Free Chemotherapy with Carboplatin and Docetaxel in Triple-Negative, Early-Stage Breast Cancer: A Multicentric Analysis of Feasibility and Rates of Pathologic Complete Response

3. Metronomic chemotherapy: new rationale for new directions

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy;Clinical and Experimental Medicine;2024-08-28

2. Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy;Frontiers in Cell and Developmental Biology;2024-05-15

3. Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells;Viruses;2024-04-05

4. New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy;Frontiers in Immunology;2024-03-21

5. Update on current and new potential immunotherapies in breast cancer, from bench to bedside;Frontiers in Immunology;2024-02-15